photo of Douglas S. Ingram
Douglas S. Ingram
President and Chief Executive Officer

“We know why we get up every day and work as hard as we do. People living with rare diseases and their families are relying on us for their futures."

Read more
photo of Diane Berry
Diane Berry, PhD
Senior Vice President, Global Health Policy, Government and Patient Affairs

"We have this culture of innovating. And I don't just mean the science but also on healthcare policy. Everything we do is pretty unprecedented.” 

Read more
Ryan E. Brown
Ryan E. Brown
Senior Vice President, General Counsel

“I love being in an environment where we challenge thinking. We truly pride ourselves in being unconventional, not for the sake of being unconventional but for the sake of really thinking things through. We're not going to accept the benchmark as the way things are done.”

Read more
William Ciambrone
William F. Ciambrone
Executive Vice President, Technical Operations

"From my very early conversations with the Sarepta team, it was apparent that patient focus was real at Sarepta, and not simply a convenient phrase. I was in and decided to come out of retirement to do what I love at a company where the vision and ambition around patient care matched my own.”

Read more
photo of Ian M. Estepan
Ian M. Estepan
Executive Vice President, Chief Financial Officer

“Until my own son was born, witnessing a child with Duchenne get on therapy was the best day of my life. And I thought, imagine how I’ll feel if we can reach more kids. That’s why I ended up joining Sarepta.”

Read more
Dallan Murray
Dallan Murray
Senior Vice President, Chief Commercial Officer

“I was drawn to Sarepta by the meaningful mission, the cutting-edge science and the belief that the future of the industry is in the potential to transform lives through precision genetic medicine.” 

Read more
photo of Gilmore O'Neill
Gilmore O'Neill, MB, MMSC
Executive Vice President, R&D and Chief Medical Officer

“I met the parents of a young boy with Duchenne muscular dystrophy. They said, ‘We’re so grateful you’re developing this gene therapy, but we’re really worried because our son is deteriorating fast.’ Well, we have a sort of sacred responsibility to help him and all the other boys he represents. We cannot stumble. We cannot slow down. We all feel that urgency here.”

Read more
photo of Louise Rodino-Klapac
Louise Rodino-Klapac, PhD
Executive Vice President, Chief Scientific Officer

“I’m here to bring gene therapy to life. We have to be creative; we need to transform the paradigm. There isn’t a path to guide us. We’re making the path.”

Read more

Meet Sarepta's Board of Directors

M. Kathleen Behrens, PhD
Chairwoman

M. Kathleen Behrens, PhD, has served as a member of our Board since March 2009 and Chairperson of the Board since April 2015. She also serves as a member and Chair of the Audit committee and as a member of the Research and Development committee of the Board.

Read more
Richard J. Barry

Richard J. Barry, a long-time stockholder of the Company, has served as a member of our Board since June 2015. He serves as member and Chair of the Nominating and Corporate Governance committee and as a member of the Audit committee and the Compensation committee.

Read more
Mary Ann Gray, PhD

Mary Ann Gray, PhD was elected to our Board in December 2018. She also serves as a member of the Audit, Compensation and Nominating and Corporate Governance committees. 

Read more
Douglas S. Ingram
President and Chief Executive Officer

Doug Ingram has served as President, CEO, and board member since 2017.

Read more
Claude Nicaise, MD

Claude Nicaise, MD has served as a member of our Board since June 2015. He currently serves as Chair of our Compensation committee. 

Read more
Hans Wigzell, MD, PhD

Hans Wigzell, MD, PhD, has served as a member of our Board since June 2010. He serves as Chair of the Research and Development Committee and as a member of the Nominating and Corporate Governance Committee.

Read more

Meet Sarepta's Scientific Advisory Board

Annemieke Aartsma-Rus, PhD

Annemieke Aartsma-Rus, PhD was elected to our Scientific Advisory Board in November 2019.

Read more
Carsten Bönnemann, MD

Carsten Bönnemann, MD was elected to our Scientific Advisory Board in December of 2019.

Read more
Joy Cavagnaro, PhD, DABT, Fellow ATS

Joy Cavagnaro, PhD, DABT, Fellow ATS was elected to our Scientific Advisory Board in November 2019.

Read more
Kay Davies, PhD, DBE FMedSci FRS

Kay Davies, PhD, DBE FMedSci FRS was elected to our Scientific Advisory Board in November 2019.

Read more
Steven Gray, PhD

Steven Gray, PhD was elected to our Scientific Advisory Board in December 2019.

Read more
Angela J. Russell, DPhil

Angela J. Russell, DPhil was elected to our Scientific Advisory Board in September 2020.

Read more